GlobeNewswire

Howard Welgus, M.D., Chief Medical Officer of Arcutis

Howard Welgus

We believe roflumilast cream has the potential to be a once daily treatment that benefits patients with plaque psoriasis who currently lack suitable treatment options.
Format

JPEG

Source

Arcutis Biotherapeutics, Inc.

Downloads